Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2026-03-03 @ 3:05 PM
Study NCT ID:
NCT00093002
Status:
COMPLETED
Last Update Posted:
2008-06-12
First Post:
2004-09-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-06
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2007-07
Completion Date Type:
ACTUAL
First Submit Date:
2004-09-28
First Submit QC Date:
None
Study First Post Date:
2004-09-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-06-11
Last Update Post Date:
2008-06-12
Last Update Post Date Type:
ESTIMATED